Cargando…

Comparison of Effectiveness and Safety of Ustekinumab and Adalimumab As Induction or Maintenance Therapy in Patients With Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis

This meta-analysis has been conducted to compare ustekinumab and adalimumab as induction or maintenance therapy in patients with moderate to severe Crohn's disease (CD). The current meta-analysis was conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chenna, Venkata Sai Harshabhargav, Nagi, Talwinder K, Suarez, Zoilo K, Hernandez, Oscar L, Nageye, Maymona E, Reyaz, Nafisa, Reyaz, Ibrahim, Ali, Neelum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Family/General Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226155/ https://www.ncbi.nlm.nih.gov/pubmed/37255887 http://dx.doi.org/10.7759/cureus.38277

Ejemplares similares

Comparison of High Ligation Versus Low Ligation of the Inferior Mesenteric Artery (IMA) on Short-Term and Long-Term Outcomes in Sigmoid Colon and Rectal Cancer Surgery: A Meta-analysis
por: Reyaz, Ibrahim, et al.
Publicado: (2023)

Dormant Crohn's Disease Reactivated by Clostridioides difficile Infection
por: Hernandez, Oscar L, et al.
Publicado: (2023)

Unilateral Choroidal Granuloma and a Pupillary Abnormality in a Case of Miliary Tuberculosis: A Dilemma for the Physician
por: Jojo, Vijaya, et al.
Publicado: (2022)

The Association between Clinical Response to Ustekinumab and Immunogenicity to Ustekinumab and Prior Adalimumab
por: Chiu, Hsien-Yi, et al.
Publicado: (2015)

Duodenal Fibrosis Mimicking Neoplastic Obstructive Hepatopathy in the Setting of Lynch Syndrome
por: Hernandez, Oscar L, et al.
Publicado: (2023)

Isotretinoin-Induced Distal Ileitis Mimicking Crohn’s Disease
por: Pereira-Nunes, Joana, et al.
Publicado: (2023)

A Rare Case of Achalasia Sigmoid Esophagus Obstructed by Food Bolus
por: Vallejo, Charles, et al.
Publicado: (2023)

A Twist in Crohn’s Disease: A Rare Case of Gastric Volvulus
por: Abideen, Zain U, et al.
Publicado: (2020)

Severity of Psychologic Stressors Reflects Course of Crohn’s Disease in Two Siblings
por: Budiselic, Jessica, et al.
Publicado: (2021)

Successful Treatment of Oral Crohn’s Disease by Ustekinumab
por: Jukema, Jelmer B, et al.
Publicado: (2020)

Severe Crohn’s Disease With Intra-abdominal Fistula: First Reported Case From Tanzania
por: Kassam, Nadeem, et al.
Publicado: (2022)

Prevalence of Gallstones in Ulcerative Colitis and Crohn’s Disease: A Systematic Review and Meta-Analysis
por: Baig, Mirza M. A, et al.
Publicado: (2022)

Basidiobolomycosis Mimicking Fistulizing Crohn’s Disease: A Case Report From Saudi Arabia
por: Meeralam, Yaser, et al.
Publicado: (2023)

Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden
por: Hansson-Hedblom, Amanda, et al.
Publicado: (2018)

Clinical utility of ustekinumab in Crohn’s disease
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)

Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's Disease
por: Krugliak Cleveland, Noa, et al.
Publicado: (2020)

Seasonal variation in in-hospital outcomes of Takotsubo-syndrome-related admissions: A National Inpatient Analysis, 2019
por: Desai, Rupak, et al.
Publicado: (2022)

Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn’s Disease
por: Dubinsky, Marla, et al.
Publicado: (2023)

Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007)

Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn’s disease
por: Tuskey, Anne, et al.
Publicado: (2014)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Okita, Aline Lissa, et al.
Publicado: (2020)

Adalimumab/ustekinumab/vedolizumab: COVID-19 infection: 7 case reports
Publicado: (2022)

Crohn’s Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review
por: Kodali, Athri, et al.
Publicado: (2023)

Comparative Effectiveness of Ustekinumab Versus Adalimumab in Induction of Clinical Response and Remission in Crohn’s Disease: Experience of a Real-World Cohort at a Tertiary Care Inflammatory Bowel Disease Referral Center
por: Ahmed, Zunirah, et al.
Publicado: (2019)

Rapid Resolution of Vulvar Crohn's Disease With Ustekinumab
por: Stoleru, Gianna, et al.
Publicado: (2020)

Enhancing Gingival Phenotype With Vestibuloplasty and Free Gingival Graft: Improving Maintenance of Regular Oral Hygiene
por: Gogoi, Anootpal
Publicado: (2022)

Should vitamin B(12) tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B(12) maintenance therapy for Alberta seniors
por: Houle, Sherilyn K D, et al.
Publicado: (2014)

Acute pain management among patients with opioid maintenance therapy: specificities and difficulties identified in primary care: a qualitative study
por: Guillou Landreat, Morgane, et al.
Publicado: (2021)

Psychological Co-morbidity in Children with Specific Learning Disorders
por: Sahoo, Manoj K., et al.
Publicado: (2015)

Myositis as an Extraintestinal Manifestation of Ulcerative Colitis: A Case Report and Literature Review
por: Nagi, Talwinder K, et al.
Publicado: (2023)

Adalimumab for the treatment of Crohn’s disease
por: Cassinotti, Andrea, et al.
Publicado: (2008)

Ustekinumab for Successful Treatment of Refractory Esophageal Crohn’s Disease
por: Barkin, Jodie A., et al.
Publicado: (2016)

Metastatic Vulval Crohn’s Disease With Good Outcome on Ustekinumab
por: Lim, Yizhe, et al.
Publicado: (2021)

Process evaluation of the Data-driven Quality Improvement in Primary Care (DQIP) trial: case study evaluation of adoption and maintenance of a complex intervention to reduce high-risk primary care prescribing
por: Grant, Aileen, et al.
Publicado: (2017)

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients
por: Gebeyehu, Gerum Gashaw, et al.
Publicado: (2022)

Delayed Presentation of Drug-Induced Hepatic Injury
por: Ahmed, Shohana, et al.
Publicado: (2020)

Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies
por: Hibi, Toshifumi, et al.
Publicado: (2017)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
por: Martora, Fabrizio, et al.
Publicado: (2023)

DiGeorge Syndrome With Absence of Speech: A Rare Case
por: Jayaprakasan, Srilakshmi K, et al.
Publicado: (2023)

Severe Acetaminophen Toxicity From the Use of Oxycodone-Acetaminophen With Normal Liver Function Tests and a Completely Asymptomatic Course of Hospitalization
por: Haider, Muhammad Adnan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cq45m7s5in1ims13avuou1c82a